Primary Health Insurance:
United Health Care
North Mississippi Acclaim
The information below is to help you decide whether or not to have a LipiFlow Treatment. Please carefully read it in its entirety. Ask your doctor any questions that you may have about the information in this document prior to having a LipiFlow Treatment.
The surface of the eye is covered in a lining of tears called the tear film. The tear film is made up of three layers: a Lipid (oil) layer, which lubricates and prevents evaporation of the tears; an Aqueous (water) layer, which nourishes and protects the eye surface; and a Mucin layer, which adheres to the eye. Since the tear film is exposed directly to the air, the protective lipid layer is essential to maintaining a healthy tear film on the eye. When the protective lipid layer of the tear film is lacking, the eye surface can become irritated and dry eye symptoms can occur.
Evaporative Dry Eye is a disease that results from not having enough lipid in the tear film to protect the eye. Evaporative dry eye is most often caused by a blockage or obstruction of the eyelid glands, called the Meibomian Glands, which produce the lipid layer of the tear film. Meibomian Gland Dysfunction is a disease that results from the formation of plugs inside the glands, which obstruct gland openings and limit the lipid secreted by the glands into the tears.
The LipiFlow System is a medical device used by a doctor to apply heat and pressure to the eyelids to allow the lipids from the blocked eyelid glands to flow into the tear film. Your doctor will determine if the LipiFlow System is an appropriate treatment option for you based on a complete exam of your eye health, including an evaluation for blocked glands and associated dry eye symptoms.
The LipiFlow System is intended for the application of localized heat and pressure therapy in adult patients with chronic cystic conditions of the eyelids, including meibomian gland dysfunction (MGD), also known as evaporative dry eye or lipid deficiency dry eye.
Possible alternative treatments for MGD and evaporative dry eye include:
The 12-minute treatment will begin with you either resting in a reclined chair or lying comfortably on a table in a procedure room. Your doctor will place 1-2 drops of a mild anesthetic in the eye(s) to be treated. Your doctor will gently fit the LipiFlow (Disposable) eyepiece under your eyelids. You will be asked to close your eyes gently around the eyepiece and keep them closed. The LipiFlow will be activated. You will begin to feel both gentle pressure and warmth on your eyelid. The eyepiece will become gradually warmer on your eyelids. Once the temperature reaches a therapeutic range, the device will maintain this temperature for 2 minutes at a constant pressure. This is when the glands are being brought to the appropriate temperature to begin melting the blockages within the glands. At the end of the 2 minutes, the pressure will be released briefly. Next, the temperature will be maintained but the pressure will go through different modes, including slow increasing pressure and pulsation, for several cycles throughout the remaining 10 minutes of treatment. This is done to facilitate removing the blockages from the glands.
The LipiFlow System should not be used in patients with the following conditions. Use of the device in patients with these conditions may cause injury. The safety and effectiveness of the device have not been studied in patients with these conditions. Ask your doctor if you have any of the following conditions.
The eyepiece used for treatment (Disposable) may not fit all eyes, such as eyes with small eyelid anatomy. Use of the LipiFlow System is not recommended in patients with the following conditions. Patients with these conditions may have reduced treatment effectiveness because these conditions may cause eye symptoms unrelated to cystic meibomian glands. The safety and effectiveness of the device have not been studied in patients with these conditions. Ask your doctor if you have any of the following conditions.
In addition, the treatment procedure may loosen previously inserted punctual plugs, which may worsen the patient’s dry eye symptoms.
You should be aware of the following warnings related to the LipiFlow System.
There is no guarantee that you will receive any medical benefit as a result of the LipiFlow treatment. It is possible that your dry eye symptoms and blocked eyelid glands will improve. It is also possible that your condition will remain the same or worsen.
Potential adverse effects that may occur as a result of the procedure include, but are not limited to the onset or increase in:
Potential serious adverse events that are not anticipated because of the device mitigations to prevent occurrence include:
In addition, the LipiFlow treatment may involve risks that are unforeseeable. There is always the possibility that you will have an adverse event or problem that is currently unknown and unexpected. You should discuss any questions or concerns you might have with your doctor. If you experience any problems during treatment, it is important that you tell your doctor.